Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype

被引：0
|
作者：
Vanhove, Thomas [1 ]
Annaert, Pieter [2 ]
Kuypers, Dirk R. J. [1 ]
机构：
[1] Univ Hosp Leuven, Nephrol & Renal Transplantat, Leuven, Belgium
[2] Univ Leuven, KU Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
420.13
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [31] Effect of CYP3A5 genotype on the relationship between hepatic CYP3A activity and CYP3A4 and CYP3A5 mRNA expression
    Kolwankar, D
    Ho, H
    Ethell, B
    Vuppalanchi, R
    Marri, SR
    Wrighton, SA
    Jones, DR
    Hall, SD
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [32] Effect of CYP3A4, CYP3A5, MDR1 and POR Genetic Polymorphisms in Immunosuppressive Treatment in Chilean Kidney Transplanted Patients
    Contreras-Castillo, Stephania
    Plaza, Anita
    Stojanova, Jana
    Navarro, Gustavo
    Carmona, Rodolfo
    Corvalan, Fernando
    Cerpa, Leslie
    Sandoval, Christopher
    Munoz, Daniel
    Leiva, Marina
    Castaneda, Luis E.
    Farias, Nayaret
    Alvarez, Carolina
    Llull, Gabriel
    Mezzano, Sergio
    Ardiles, Leopoldo
    Varela, Nelson
    Rodriguez, Maria S.
    Flores, Claudio
    Cayun, Juan Pablo
    Krall, Paola
    Quinones, Luis A.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [33] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [34] Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination
    Scheibner, Aileen
    Remmel, Rory
    Schladt, David
    Oetting, William S.
    Guan, Weihua
    Wu, Baolin
    Dorr, Casey
    Israni, Ajay
    Jacobson, Pamala A.
    PHARMACOTHERAPY, 2018, 38 (07): : E46 - E52
  • [35] Description of CYP3A4*22 and CYP3A5*3 frequencies and impact on first tacrolimus (TAC) doses in renal transplant recipients
    Lori, L.
    Zaidan, M.
    Furlan, V.
    Bouligand, J.
    Becquemont, L.
    Verstuyft, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 159 - 160
  • [36] Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients
    Mendes, J.
    Martinho, A.
    Simoes, O.
    Mota, A.
    Breitenfeld, L.
    Pais, L.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) : 840 - 842
  • [37] Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus
    Hesselink, DA
    van Schaik, RHN
    van der Heiden, IP
    van der Werf, M
    Gregoor, PJHS
    Lindemans, J
    Weimar, W
    van Gelder, T
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (03) : 245 - 254
  • [38] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [39] EFFECTS OF RECIPIENTS' MDR1 AND CYP3A5 GENOTYPES ON TACROLIMUS DOSE REQUIREMENTS AFTER LIVER TRANSPLANTATION
    Maschmeier, M.
    Cicinnati, V. R.
    Iacob, S.
    Radtke, A.
    Schomacher, T.
    Kabar, I.
    Huesing, A.
    Wilms, C.
    Schmidt, H. H.
    Beckebaum, S.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 29 - 29
  • [40] Effect of CYP3A4* 22, CYP3A5* 3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation
    Moes, D. J. A. R.
    Swen, J. J.
    den Hartigh, J.
    van der Straaten, T.
    van der Heide, J. J. Homan
    Sanders, J. S.
    Bemelman, F. J.
    de Fijter, J. W.
    Guchelaar, H. J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (02):
12345